279 related articles for article (PubMed ID: 19252501)
1. Regulation of endocytosis via the oxygen-sensing pathway.
Wang Y; Roche O; Yan MS; Finak G; Evans AJ; Metcalf JL; Hast BE; Hanna SC; Wondergem B; Furge KA; Irwin MS; Kim WY; Teh BT; Grinstein S; Park M; Marsden PA; Ohh M
Nat Med; 2009 Mar; 15(3):319-24. PubMed ID: 19252501
[TBL] [Abstract][Full Text] [Related]
2. The pleckstrin homology domain of phospholipase D1 accelerates EGFR endocytosis by increasing the expression of the Rab5 effector, rabaptin-5.
Park MH; Choi KY; Min do S
Exp Mol Med; 2015 Dec; 47(12):e200. PubMed ID: 26680696
[TBL] [Abstract][Full Text] [Related]
3. Oxygen-mediated endocytosis in cancer.
Wang Y; Ohh M
J Cell Mol Med; 2010 Mar; 14(3):496-503. PubMed ID: 20082654
[TBL] [Abstract][Full Text] [Related]
4. Endocytic function of von Hippel-Lindau tumor suppressor protein regulates surface localization of fibroblast growth factor receptor 1 and cell motility.
Hsu T; Adereth Y; Kose N; Dammai V
J Biol Chem; 2006 Apr; 281(17):12069-80. PubMed ID: 16505488
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K; Makino Y; Pereira T; Poellinger L
EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
[TBL] [Abstract][Full Text] [Related]
6. The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 alpha by a von Hippel-Lindau protein-independent mechanism.
Tang TT; Lasky LA
J Biol Chem; 2003 Aug; 278(32):30125-35. PubMed ID: 12761217
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
8. Delayed onset of positive feedback activation of Rab5 by Rabex-5 and Rabaptin-5 in endocytosis.
Zhu H; Qian H; Li G
PLoS One; 2010 Feb; 5(2):e9226. PubMed ID: 20169068
[TBL] [Abstract][Full Text] [Related]
9. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
10. Interplay between receptor tyrosine kinases and hypoxia signaling in cancer.
Glück AA; Aebersold DM; Zimmer Y; Medová M
Int J Biochem Cell Biol; 2015 May; 62():101-14. PubMed ID: 25747905
[TBL] [Abstract][Full Text] [Related]
11. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein.
Groulx I; Lee S
Mol Cell Biol; 2002 Aug; 22(15):5319-36. PubMed ID: 12101228
[TBL] [Abstract][Full Text] [Related]
12. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ
IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review.
Vriend J; Reiter RJ
Biochim Biophys Acta; 2016 Apr; 1865(2):176-83. PubMed ID: 26899267
[TBL] [Abstract][Full Text] [Related]
14. Endothelial function of von Hippel-Lindau tumor suppressor gene: control of fibroblast growth factor receptor signaling.
Champion KJ; Guinea M; Dammai V; Hsu T
Cancer Res; 2008 Jun; 68(12):4649-57. PubMed ID: 18559510
[TBL] [Abstract][Full Text] [Related]
15. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing.
Kaelin WG
Biochem Biophys Res Commun; 2005 Dec; 338(1):627-38. PubMed ID: 16153592
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
17. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
Petrella BL; Brinckerhoff CE
Cancer Biol Ther; 2009 Jul; 8(14):1389-401. PubMed ID: 19483472
[TBL] [Abstract][Full Text] [Related]
18. Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas.
Cuevas Y; Hernández-Alcoceba R; Aragones J; Naranjo-Suárez S; Castellanos MC; Esteban MA; Martín-Puig S; Landazuri MO; del Peso L
Cancer Res; 2003 Oct; 63(20):6877-84. PubMed ID: 14583486
[TBL] [Abstract][Full Text] [Related]
19. Signal pathway of hypoxia-inducible factor-1alpha phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells.
Kwon SJ; Song JJ; Lee YJ
Clin Cancer Res; 2005 Nov; 11(21):7607-13. PubMed ID: 16278378
[TBL] [Abstract][Full Text] [Related]
20. Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau.
Roberts AM; Ohh M
Curr Opin Oncol; 2008 Jan; 20(1):83-9. PubMed ID: 18043261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]